Literature DB >> 17342215

Financial conflicts of interest in psychiatry.

Giovanni A Fava1.   

Abstract

The issue of conflicts of interest has brought clinical medicine to an unprecedented crisis of credibility. The situation of psychiatry does not appear to be different from other areas of medicine. The problems caused by the increasing financial ties between the pharmaceutical industry and researchers and clinicians can be addressed only by a complex effort encompassing both the establishment of lines of support of independent researchers who are free of substantial conflicts of interest and better disclosure policies and conduct regulations as to financial ties. Such effort requires a bold shift from current, largely inadequate strategies. In the long run it may entail, however, substantial advantages to patients, clinicians, researchers, the health industry and the civil society at large. Psychiatry, in view of its humanistic and social roots, may lead this effort.

Entities:  

Year:  2007        PMID: 17342215      PMCID: PMC1805729     

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  36 in total

1.  Pharmaceutical advertising revenue and physician organizations: how much is too much?

Authors:  P A Glassman; J Hunter-Hayes; T Nakamura
Journal:  West J Med       Date:  1999-10

2.  Don't bite the hand that feeds you.

Authors:  J Lexchin
Journal:  West J Med       Date:  1999-10

3.  Conflict of interest and special interest groups. The making of a counter culture.

Authors:  G A Fava
Journal:  Psychother Psychosom       Date:  2001 Jan-Feb       Impact factor: 17.659

4.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors:  Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

Review 5.  Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Authors:  Hans Melander; Jane Ahlqvist-Rastad; Gertie Meijer; Björn Beermann
Journal:  BMJ       Date:  2003-05-31

Review 6.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

7.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors:  Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

Review 8.  Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Authors:  Stephan Heres; John Davis; Katja Maino; Elisabeth Jetzinger; Werner Kissling; Stefan Leucht
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

9.  Scientific journals and their authors' financial interests: a pilot study.

Authors:  S Krimsky; L S Rothenberg; P Stott; G Kyle
Journal:  Psychother Psychosom       Date:  1998 Jul-Oct       Impact factor: 17.659

10.  The intellectual crisis of psychiatric research.

Authors:  Giovanni A Fava
Journal:  Psychother Psychosom       Date:  2006       Impact factor: 17.659

View more
  11 in total

1.  The new impact factor of World Psychiatry.

Authors:  Mario Maj
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

Review 2.  Financial and non-financial conflicts of interests in psychiatry.

Authors:  Mario Maj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-09       Impact factor: 5.270

3.  The quest for a meaningful evidence base in psychiatry.

Authors:  Robin Emsley; Sue Hawkridge
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

4.  US studies may overestimate effect sizes in softer research.

Authors:  Daniele Fanelli; John P A Ioannidis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

5.  [Conflict of interest declarations in scientific publications].

Authors:  H-J Möller
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

6.  Should the drug industry work with key opinion leaders? No.

Authors:  Giovanni A Fava
Journal:  BMJ       Date:  2008-06-21

7.  Experience counts.

Authors:  Ricardo Araya
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

8.  Are psychiatrists an endangered species? Observations on internal and external challenges to the profession.

Authors:  Heinz Katschnig
Journal:  World Psychiatry       Date:  2010-02       Impact factor: 49.548

Review 9.  How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding.

Authors:  Michael P Hengartner
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-08

Review 10.  Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants' Efficacy and Harm.

Authors:  Michael P Hengartner
Journal:  Front Psychiatry       Date:  2017-12-07       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.